These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36338998)

  • 21. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
    Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
    Front Genet; 2022; 13():938259. PubMed ID: 35910212
    [No Abstract]   [Full Text] [Related]  

  • 22. A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma.
    Han J; Hu Y; Liu S; Jiang J; Wang H
    J Oncol; 2022; 2022():8489387. PubMed ID: 35847354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer.
    Li D; Wu X; Fan X; Cheng C; Li D; Zhang W
    Ann Transl Med; 2022 Nov; 10(22):1232. PubMed ID: 36544685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.
    Zhou Y; Shu Q; Fu Z; Wang C; Gu J; Li J; Chen Y; Xie M
    Front Genet; 2022; 13():959456. PubMed ID: 35938036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma.
    Mo X; Hu D; Yang P; Li Y; Bashir S; Nai A; Ma F; Jia G; Xu M
    Front Oncol; 2022; 12():927706. PubMed ID: 35936736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer.
    Zhu Z; Zhao Q; Li S; Weng J; Guo T; Zhu C; Xu Y
    Front Genet; 2022; 13():984743. PubMed ID: 36467996
    [No Abstract]   [Full Text] [Related]  

  • 27. Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma.
    Huang QR; Li JW; Yan P; Jiang Q; Guo FZ; Zhao YN; Mo LG
    Front Neurol; 2022; 13():861438. PubMed ID: 35832170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer.
    Wang Q; Xu Y
    Front Pharmacol; 2022; 13():1065701. PubMed ID: 36532719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics.
    Zhang Z; Wang B; Xu X; Xin T
    Front Genet; 2022; 13():1036460. PubMed ID: 36386799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs.
    Guo Y; Jiang Z; Chen Q; Xie D; Zhou Y; Yin W; Wang Z; Wang B; Ren C; Jiang X
    Front Immunol; 2023; 14():1291385. PubMed ID: 38022537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma.
    Cui G; Liu J; Wang C; Gu R; Wang M; Sun Z; Wei F
    Front Oncol; 2022; 12():1007918. PubMed ID: 36212459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Role of Cuproptosis-Related Lncrna in Prognosis and Immunotherapy of Thyroid Carcinoma.
    Cai Y; Niu B; Gao J; Su H
    Iran J Public Health; 2023 May; 52(5):995-1007. PubMed ID: 37484723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma.
    Li YJ; Li HY; Zhang Q; Wei SL
    Front Genet; 2022; 13():942785. PubMed ID: 35942287
    [No Abstract]   [Full Text] [Related]  

  • 34. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs.
    Wen J; Wang Y; Luo L; Peng L; Chen C; Guo J; Ge Y; Li W; Jin X
    Front Oncol; 2020; 10():578809. PubMed ID: 33330055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients.
    Wu J; Lu L; Wang C; Jiang F
    J Oncol; 2022; 2022():8164756. PubMed ID: 35646114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.
    Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J
    Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778
    [No Abstract]   [Full Text] [Related]  

  • 38. Machine learning predicts cuproptosis-related lncRNAs and survival in glioma patients.
    Hao S; Gao M; Li Q; Shu L; Wang P; Hao G
    Sci Rep; 2024 Sep; 14(1):22323. PubMed ID: 39333603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment.
    Duan H; Shen Y; Wang C; Xia W; Zhang S; Yu S; Xu D; Cao Q; Liu H; Shen H
    Int J Gen Med; 2024; 17():161-174. PubMed ID: 38268861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma.
    Liu B; Pang K; Feng C; Liu Z; Li C; Zhang H; Liu P; Li Z; He S; Tu C
    Front Genet; 2022; 13():1063057. PubMed ID: 36568384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.